All Stories

  1. Consistent response to guselkumab treatment between Hispanic and non-Hispanic patients with psoriasis: an analysis from VOYAGE 1 and VOYAGE 2

    Article • Journal of Dermatological Treatment, October 2019, Taylor & Francis

    Professor Luis Puig

  2. Biosimilars for the treatment of psoriasis

    Article • Expert Opinion on Biological Therapy, July 2019, Taylor & Francis

    Professor Luis Puig

  3. Dupilumab improves patient-reported symptoms of atopic dermatitis, symptoms of anxiety and depression, and health-related quality of life in moderate-to-severe atopic dermatitis: analysis of pooled data from the randomized trials SOLO 1 and SOLO 2

    Article • Journal of Dermatological Treatment, June 2019, Taylor & Francis

    Professor Luis Puig, Andreas Wollenberg, MD YOKO KATAOKA

  4. Guselkumab for the treatment of adults with moderate to severe plaque psoriasis

    Article • Expert Review of Clinical Immunology, April 2019, Taylor & Francis

    Professor Luis Puig

  5. Drug survival of conventional systemic and biologic therapies for moderate-to-severe psoriasis in clinical practice in Spain: prospective results from the SAHARA study

    Article • Journal of Dermatological Treatment, March 2019, Taylor & Francis

    Professor Luis Puig

  6. Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter study

    Article • Journal of Dermatological Treatment, March 2019, Taylor & Francis

    Professor Luis Puig

  7. Benefit-risk profile of tofacitinib in patients with moderate-to-severe chronic plaque psoriasis: pooled analysis across six clinical trials

    Article • British Journal of Dermatology, October 2018, Wiley

    Professor Luis Puig

  8. Treatment of patients with plaque psoriasis with secukinumab in a real-life setting: a 52-week, multicenter, retrospective study in Spain

    Article • Journal of Dermatological Treatment, September 2018, Taylor & Francis

    Professor Luis Puig, Gustavo Deza

  9. Subclinical enthesopathy of extensor digitorum tendon is highly prevalent and associated with clinical and ultrasound alterations of the adjacent fingernails in patients with psoriatic disease

    Article • Journal of the European Academy of Dermatology and Venereology, May 2018, Wiley

    Professor Luis Puig

  10. Lower lip capillary malformation associated with lymphatic malformation without overgrowth: Part of the spectrum of CLAPO syndrome

    Article • Pediatric Dermatology, May 2018, Wiley

    Professor Luis Puig

  11. Differential effects of secukinumab vs. ustekinumab for treatment of psoriasis on quality of life, work productivity and activity impairment: a structural equation modelling analysis

    Article • British Journal of Dermatology, April 2018, Wiley

    Professor Luis Puig

  12. Redefining the therapeutic objective in psoriatic patients candidates for biological therapy

    Article • Journal of Dermatological Treatment, November 2017, Taylor & Francis

    Professor Luis Puig

  13. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial

    Article • British Journal of Dermatology, October 2017, Wiley

    Professor Luis Puig

  14. Epithelial-to-mesenchymal transition contributes to invasion in squamous cell carcinomas originated from actinic keratosis through the differentiated pathway, whereas proliferation plays a more significant role in the classical pathway

    Article • Journal of the European Academy of Dermatology and Venereology, October 2017, Wiley

    Dr María Teresa Fernández Figueras, Professor Luis Puig

  15. Choice of first-line biologic therapy in psoriasis: understanding the past and shaping the future?

    Article • British Journal of Dermatology, September 2017, Wiley

    Professor Luis Puig

  16. The role of IL-23 and the IL-23/TH 17 immune axis in the pathogenesis and treatment of psoriasis

    Article • Journal of the European Academy of Dermatology and Venereology, August 2017, Wiley

    Professor Luis Puig

  17. European consensus statement on phenotypes of pustular psoriasis

    Article • Journal of the European Academy of Dermatology and Venereology, August 2017, Wiley

    Professor Luis Puig

  18. Infantile hemangiomas with minimal or arrested growth associated with soft tissue hypertrophy: a case series of 10 patients

    Article • Journal of the European Academy of Dermatology and Venereology, August 2017, Wiley

    Professor Luis Puig, Sergi Planas-Ciudad

  19. Reaching complete or near-complete resolution of psoriasis: benefit and risk considerations

    Article • British Journal of Dermatology, July 2017, Wiley

    Professor Luis Puig

  20. Quantitative Evaluations of Time-Course and Treatment Effects of Systemic Agents for Psoriasis: A Model-Based Meta-Analysis

    Article • Clinical Pharmacology & Therapeutics, June 2017, Wiley

    Professor Luis Puig

  21. A Topical Treatment Optimization Programme (TTOP) improves clinical outcome for calcipotriol/betamethasone gel in psoriasis: results of a 64-week multinational randomized phase IV study in 1790 patients (PSO-TOP)

    Article • British Journal of Dermatology, June 2017, Wiley

    Professor Luis Puig

  22. The safety of ustekinumab for the treatment of psoriatic arthritis

    Article • Expert Opinion on Drug Safety, May 2017, Taylor & Francis

    Professor Luis Puig

  23. Psoriasis: inequality or individualized care?

    Article • British Journal of Dermatology, May 2017, Wiley

    Professor Luis Puig

  24. A European subset analysis from the population-based Multinational Assessment of Psoriasis and Psoriatic Arthritis shows country-specific features: results from psoriasis patients in Spain

    Article • Journal of the European Academy of Dermatology and Venereology, April 2017, Wiley

    Professor Luis Puig

  25. Corrigendum

    Article • Expert Review of Clinical Immunology, April 2017, Taylor & Francis

    Professor Luis Puig

  26. Prevalence of alexithymia in patients with psoriasis and its association with disease burden: a multicentre observational study

    Article • British Journal of Dermatology, April 2017, Wiley

    Professor Luis Puig, Phyllis Spuls

  27. Psoriasis patients with psoriasis Area and Severity Index (PASI) 90 response achieve greater health-related quality-of-life improvements than those with PASI 75–89 response: results from two phase 3 studies of secukinumab

    Article • Journal of Dermatological Treatment, March 2017, Taylor & Francis

    Professor Luis Puig

  28. Registries and biologics: disease populations matter

    Article • British Journal of Dermatology, March 2017, Wiley

    Professor Luis Puig

  29. Interleukin-17 in skin: psoriasis and yonder

    Article • British Journal of Dermatology, October 2016, Wiley

    Professor Luis Puig

  30. Clear or almost clear skin improves the quality of life in patients with moderate-to-severe psoriasis: a systematic review and meta-analysis

    Article • Journal of the European Academy of Dermatology and Venereology, October 2016, Wiley

    Professor Luis Puig

  31. On clinical thresholds, clinical equivalents and indirect comparisons of biological treatments for moderate-to-severe psoriasis

    Article • Journal of Clinical Pharmacy and Therapeutics, January 2015, Wiley

    Professor Luis Puig

  32. PASI90 response: the new standard in therapeutic efficacy for psoriasis

    Article • Journal of the European Academy of Dermatology and Venereology, November 2014, Wiley

    Professor Luis Puig

  33. Predictors of biologic treatment of psoriasis: a non-interventional study

    Article • ClinicoEconomics and Outcomes Research, February 2014, Taylor & Francis

    Professor Luis Puig, Dr Qian Ding

  34. Efficacy of biologics in the treatment of moderate-to-severe plaque psoriasis: a systematic review and meta-analysis of randomized controlled trials with different time points

    Article • Journal of the European Academy of Dermatology and Venereology, August 2013, Wiley

    Professor Luis Puig